REGAN POLONE: Open Payments
NPI 1376588194 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 9 payments from 6 companies in 2025. Trend: 2023 $237 · 2024 $855 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $92 |
| AstraZeneca Pharmaceuticals LP | 1 | $83 |
| Novo Nordisk Inc | 1 | $79 |
| ABBVIE INC. | 4 | $74 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: REPATHA, FARXIGA, Ozempic, VRAYLAR, Auvelity, LEQVIO.
Industry payments across TX — which companies pay providers there.
